Founded

Address

Lilly Ventures
115 W. Washington Street
South Tower 1680
Indianapolis, IN 46204
United States

Open map


Recent investment activity

KANDO id: 30096

Corporate information

Registration country

Funding rounds

Top investment portfolio themes

Actual initial investment stage
N/A (1)

Investment activity status
Active investor

Selected investments

Displaying 1 - 25 of 36
Profile Country Date Funding
Avid Radiopharmaceuticals Inc Series D
Forma Therapeutics Inc N/A
Hemaquest Pharmaceuticals Inc Series B
InnoCentive Inc Series A
Intradigm Corp N/A
Anthera Pharmaceuticals Inc N/A
Cerulean Pharma Inc Series D
Avid Radiopharmaceuticals Inc Series A
Avid Radiopharmaceuticals Inc Series C
GlobeImmune Inc Biopharmaceuticals company. N/A
Kanisa Pharmaceuticals Inc Biopharmaceutical company employing a targeted approach to the diagnosis and treatment of cancer. N/A
Remon Medical Technologies Inc Medical device company providing smart, miniature implants. Series C
Cylene Pharmaceuticals Inc Clinical stage private company developing small molecule drugs against newly validated cancer targets. Series C
Cylene Pharmaceuticals Inc Clinical stage private company developing small molecule drugs against newly validated cancer targets. Series D
IRX Therapeutics Inc N/A
Trinity Biosystems Inc Developer of a platform for the delivery of peptides across intact mucosal surfaces. N/A
RelayHealth Corp N/A
Receptos Inc [] Series A
MedManage Systems Inc Online drug sampling provider N/A
Aileron Therapeutics Inc Developing a breakthrough proprietary peptide technology platform N/A
Hydra Biosciences Inc N/A
Bayhill Therapeutics A biopharmaceutical company focused on the translation of research into therapeutics for the treatment of autoimmune diseases. N/A
Hemaquest Pharmaceuticals Inc Series A
Hemaquest Pharmaceuticals Inc Series B
Viamet Pharmaceuticals Inc N/A

Past employees

Selected Products / Customers

Financials